Guidance

Importing medicines from the EEA after Brexit

If you import human medicines from the EU, Norway, Iceland or Liechtenstein, you鈥檒l need to review your wholesale dealer鈥檚 licence if there鈥檚 a no-deal Brexit.

This publication was withdrawn on

Documents

Details

In a no-deal Brexit existing wholesale dealers that source human medicines from an EEA State for use in the UK will need to review their existing wholesale dealer鈥檚 licence.

This guidance will apply from exit day in line with the .

Updates to this page

Published 11 March 2019
Last updated 9 October 2019 show all updates
  1. Change of text within Stay up to date box.

  2. Updated page titles and the summary to clarify that this guidance is about importing medicines from EEA countries if there's a no-deal Brexit. The rest of the content has not changed.

  3. First published.

Sign up for emails or print this page